UK animal health and genetics services provider Benchmark Holdings has set a rough guideline for the full commercial release of its anticipated sea lice treatment product, with the regulatory process "progressing towards approval in late calendar year 2020".
The product candidate, named BMK08, has continued to show around 99% effectiveness as well as "excellent animal welfare and environmental credentials" in tests, Benchmark said in its Q4 financial update [...]
Want to keep reading?
Sign up for a trial to have full access to our articles for 7 days!
Have an account? Log in here:
Enter the email address associated with your account. We'll send you instructions to reset your password.
We’ve sent a link to to change your password.
Please check your inbox to reset your password securely and easily.
redirecting...
